GlassScriptPhysician profile
Hooman Madyoon
NPI 1285696476
$23,620.28
in general payments reported to CMS, 2019-2025
58 companies · $2,730 in 2025
The $2,730 reported for 2025 was more than what 96% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,956 · 2020: $1,754 · 2021: $2,844 · 2022: $3,664 · 2023: $1,829 · 2024: $3,844 · 2025: $2,730.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,133 · Travel and Lodging: $2,250 · Education: $19.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,132.52 |
| Travel and Lodging | $2,250.36 |
| Education | $19.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $5,433.39 | 2019-2020 | |
| Boston Scientific Corporation | $2,833.33 | 2019-2025 | Jetstream Sc, Opticross 35, Lux-Dx Insertable Cardiac Monitor |
| Terumo Medical Corporation | $1,993.49 | 2024-2025 | Glidewire, Glidesheath Slender, Tr Band |
| Novartis Pharmaceuticals Corporation | $1,938.42 | 2019-2025 | |
| Abbott Laboratories | $967.14 | 2019-2023 | Emboshield Nav6 |
| Esperion Therapeutics, INC. | $810.31 | 2021-2025 | Nexletol |
| Amgen INC. | $724.12 | 2019-2025 | Repatha, Repatha |
| Kestra Medical Technology Services, INC. | $685.95 | 2022-2025 | Assure Wcd |
| Janssen Pharmaceuticals, INC | $677.39 | 2019-2024 | Xarelto |
| Endologix LLC | $638.25 | 2025 | Torus Stent Graft System, Endocross Device |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $563.61 | 2019-2025 | Lifevest |
| Novo Nordisk INC | $481.32 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Bayer Healthcare Pharmaceuticals INC. | $383.43 | 2019-2025 | |
| Siemens Medical Solutions USA, INC. | $361.91 | 2019-2025 | Naeotom Alpha |
| Pfizer INC. | $349.97 | 2019-2025 |
Show all 58 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $330.89 | 2019-2025 | Camzyos, Eliquis |
| Amarin Pharma, INC. | $306.01 | 2019-2022 | |
| Inari Medical, INC. | $289.22 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $285.27 | 2023-2024 | Inpefa |
| Astrazeneca Pharmaceuticals LP | $270.97 | 2019-2023 | Breztri, Farxiga, Wainua |
| Boehringer Ingelheim Pharmaceuticals, INC. | $250.65 | 2019-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $228.28 | 2020-2024 | Verquvo |
| Regeneron Healthcare Solutions, INC. | $224.33 | 2019-2023 | Praluent, Evkeeza |
| Abbvie INC. | $211.11 | 2020-2022 | |
| Lilly USA, LLC | $181.55 | 2020-2024 | Zepbound, Mounjaro, Jardiance |
| Angiodynamics, INC. | $173.08 | 2022-2025 | Alphavac |
| Impulse Dynamics (USA) INC. | $151.05 | 2023-2024 | Optimizer, Optimizer |
| Becton, Dickinson and Company | $148.71 | 2025 | Lutonix Drug Coated Balloon |
| Heartflow, INC. | $130.86 | 2025 | |
| Biosense Webster, INC. | $125.17 | 2022 | |
| Organogenesis INC. | $122.10 | 2023 | Puraply |
| Nuwellis, INC. | $104.92 | 2021 | |
| Alnylam Pharmaceuticals INC. | $104.63 | 2022-2023 | Amvuttra |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $89.93 | 2022-2023 | Xifaxan |
| Cordis US Corp. | $84.18 | 2024-2025 | Radial 360, Mynx Control |
| Penumbra, INC. | $82.84 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $82.40 | 2021-2023 | Arcalyst |
| Actelion Pharmaceuticals US, INC. | $73.59 | 2019-2023 | Opsumit, Uptravi |
| Currax Pharmaceuticals LLC | $65.81 | 2021-2022 | |
| Baxter Healthcare | $65.72 | 2023-2024 | Hillrom - Cardiac Ambulatory Monitor |
| Edwards Lifesciences Corporation | $58.18 | 2022 | |
| Tactile Systems Technology INC | $58.08 | 2020-2024 | Entre Plus, Flexitouch Plus |
| Arbor Pharmaceuticals, INC. | $54.36 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $48.61 | 2021 | |
| Daiichi Sankyo INC. | $46.38 | 2019-2023 | Injectafer |
| Ascensia Diabetes Care US INC. | $42.11 | 2022 | |
| Sanofi-Aventis U.S. LLC | $40.68 | 2019-2023 | |
| Medtronic Vascular, INC. | $36.44 | 2020 | |
| Ionis Pharmaceuticals, INC. | $34.10 | 2025 | Tryngolza |
| Shockwave Medical, INC | $27.05 | 2020 | |
| Amniox Medical, INC. | $25.19 | 2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $22.73 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $22.16 | 2023 | Jynarque |
| Vivus LLC | $21.33 | 2023 | Qsymia |
| Medtronic, INC. | $17.85 | 2022 | |
| Bsn Medical INC | $14.74 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $13.00 | 2021 | |
| Venclose INC. | $11.99 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hooman Madyoon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.